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In India, Vatari Guggulu has been traditionally used in the Ayurvedic system of medicine to treat rheu-
matoid arthritis (RA). The current study was undertaken to evaluate anti-arthritic activity of alcoholic
extract of Vatari Guggulu in rats. Arthritis was induced by administration of formaldehyde (2%v/v) or
Complete Freund's Adjuvant (CFA) into the sub-plantar surface of left hind paw of the animals. The
extract was administered to the rats by oral gavages in different doses. Joint swelling was measured in
formaldehyde induced arthritis. Various physical, biochemical and histopathological parameters were
determined in CFA induced arthritis. Vatari Guggulu extract (VGE) produced signiﬁcant (P < 0.05) inhi-
bition of joint swelling in both formaldehyde and CFA induced arthritis. The treatment also brought to
normalcy the increased white blood cell (WBC) count, rheumatoid factor (RF), erythrocyte sedimentation
rate (ESR), cholesterol, triglycerides and LDL with an enhancement of haemoglobin (Hb) levels and red
blood cell (RBC) count. These effects were found to be dose dependent. These effects were comparable
with standard drug indomethacin. Histo-pathological studies of the ankles of VGE treated animals
exhibited signiﬁcant improvements. VGE did not show any toxic symptoms even at a dose of 2000 mg/kg
in acute toxicity studies on rats. Thus, Vatari Guggulu, a classical Ayurvedic formulation of the Indian
System of Medicine, exhibited signiﬁcant anti-arthritic activity in formaldehyde and CFA induced
arthritis in rats. This study corroborates the claims of Ayurveda on Vatari Guggulu.
Copyright © 2016, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Rheumatoid arthritis (RA) is a chronic, inﬂammatory condition
of unknown aetiology, affecting approximately 1% of the general
population. It is a progressive, disabling, chronic multisystem dis-
ease that is characterized by pain, swelling and stiffness of the
synovial joints.1 Although spontaneous remission can occur, it often
progresses to a chronic state associated with signiﬁcant functional
disability and substantial morbidity.2
Treatment for RA is aimed at relieving pain, reducing joint
swelling, slowing or preventing joint damage and improvingþ91 7600568631 (mobile);
Patel), P_kilambi@yahoo.com
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).physical function and wellbeing. In certain cases people suffering
from arthritis have used Complimentary and Alternative Medi-
cines (CAM) involving predominantly herbal therapies,3 Vatari
Guggulu, a classical Ayurvedic formulation. It consists of a
mixture of ﬁne powders of dried pericarps of Haritaki (Terminalia
chebula Retz. F.- Combretaceae), Bibhitaka (Terminalia belerica
Roxb. F.- Combretaceae), and Amalaki (Phyllanthus emblica Linn.,
F.- Euphorbiaceae), oleo-gum resin of Guggulu-suddha (Commi-
phora mukul Engl., F.- Burseraceae), ﬁne powder of Gandhak-
suddha (puriﬁed sulphur), and Vatari Taila (Castor oil) in equal
quantities.
It is recommended in rheumatism, lower backache, sciatica,
gout, paraplegia and deformed knee in the Ayurvedic system of
medicine.4 However, no scientiﬁc study is available on anti-arthritic
activity of this formulation. Hence, the present study was under-
taken with an objective to investigate the anti-arthritic activity of
Vatari Guggulu and to correlate the changes in lipid and blood
proﬁles that occur during the disease in albino rats.rsity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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2.1. Plant materials
Oleoresin of Guggulu, fruits of Haritaki, Bibhitaka and Amalaki
were procured from a reputed herbal drug supplier, M/s. Yucca
Enterprises, Mumbai, India and were authenticated by a botanist
through morphological and microscopic studies. The samples were
also compared with the herbarium specimens deposited in the
authors' department. After removing the seeds, pericarps of Har-
itaki, Bibhitaka and Amalaki were dried thoroughly and powdered.
The powders were passed through 80 # sieve and stored. Pure
sulphur (Gandhak) and Vatari Taila (Castor oil) were of Pharmaco-
poeial grade. As per the method mentioned in Ayurveda, Guggulu
was puriﬁed using cow's urine; Gandhakwas puriﬁed by cow's milk
and ghee.5 After puriﬁcation, they were dried properly and
powdered for further use. For the preparation of Vatari Guggulu
formulation, Guggulu was ﬁrst homogenized in castor oil; powders
of other ingredients including puriﬁed Gandhak were added and
mixed well.2.2. Preparation of Vatari Guggulu extract (VGE)
Vatari Guggulu (100 g) was extracted exhaustively with ethyl
alcohol (1000 ml) by cold maceration at room temperature
(3 24 h). The extract (VGE) was initially concentrated at 50 C on a
rotary evaporator (Equitronrotevar, Medical Instrument
Manufacturing Company. Mumbai, India) and then dried in a vac-
uum desiccators till free from solvent.2.3. Animals
Male Wistar albino rats (200e250 g) maintained in the in-
stitute's animal house, were used for the experiments. The animals
were maintained at a temperature of 25 ± 2 C, relative humidity of
75 ± 5% and 12 h darkelight cycle. Standard pellet diet (M/s. Hin-
dustan Lever Ltd., Bangalore, India) and water were given ad libi-
tum. The study protocol was approved by the Institutional Animal
Ethical Committee (IAEC) for the Purpose of Control and Supervi-
sion of Experiments on Animals (CPCSEA), India and the experi-
ments were conducted in accordance with the principles
prescribed for laboratory animal use (letter Nos. PIPH 06/12 and
PIPH 36/13).2.4. Acute toxicity study
Acute toxicity study was carried out for the VGE asmentioned in
OECD Guidelines (2001).6 VGE (2000 mg/kg body weight), sus-
pended in water with 0.5% gum acacia, was orally administered to
overnight-fasted, healthy rats (n ¼ 6). The animals were observed
continuously for 24 h for mortality and then for the next 14 days.2.5. Animal grouping and dosing
In both formaldehyde and CFA induced arthritis models, animals
were divided into six groups of six animals each. Group I served as a
normal control receiving 0.5% gum acacia in water as a vehicle.
group II served as arthritic disease control, group III was adminis-
tered standard indomethacin (10 mg/kg p.o.),7 groups IV, V and VI
were given 135 mg/kg, 270 mg/kg and 540 mg/kg (p.o.) VGE
(reconstituted in water with 0.5% gum acacia) respectively. All the
test drugs and vehicle were given orally through oral gavages.2.6. Formaldehyde induced arthritis
The test samples were given for a period of 10 days. Thirty mi-
nutes after administration of the vehicle/drug, arthritis was
induced by subplantar administration of 0.1 ml formaldehyde (2%v/
v) into the left hind paw of all the animals on day 1 and 3.8 Increase
in joint diameter was measured on days 0, 2, 4, 6, 8 and 10 as paw
volume.2.7. Paw volume in formaldehyde induced arthritis
The left hind paw volumes of all animals were measured on day
0, 2, 4, 6, 8 and 10 using digital plethysmometer (Orchid Scientiﬁc&
Innovative India Private Limited, Bombay, India). The change in paw
volume was measured as the difference between the ﬁnal and
initial paw volumes.9,102.8. Complete Freund's adjuvant (CFA) induced arthritis
Arthritis was induced by a single injection of 0.1 ml CFA, (Sigma
Aldrich, USA) into the sub-plantar surface of the left hind paw.
Indomethacin and VGE were administered each day starting from
14th day after adjuvant injection till the 28th day.11
Paw volume and body weight changes were measured during
the experiment. On the 28th day, blood was collected from animals
and the animals were sacriﬁced by cervical decapitation for histo-
pathology study of ankle joint.2.9. Paw volume and body weight in CFA induced arthritis
The left hind paw volumes of all animals were measured just
before CFA injection on day 0 and thereafter at different time in-
tervals till day 28 using Digital Plethysmometer. Body weights of
animals were measured by animal laboratory balance used for
weighing small animals.2.10. Blood analysis in CFA induced arthritis
The haematological parameters like haemoglobin (Hb), RBC,
WBC, PCV, platelet and ESR were measured by Hematology Cell
Counter (HEMA 2062, Analytical Technologies Limited, India).
Rheumatoid factor was determined by using diagnostic kit (RF
Turbilatex Tl020 from Chemelex, S.A, Barcelona). Estimation of
serum total cholesterol (TC) by Cholesterol-LS kit (Piramal Enter-
prises Limited, Navi Mumbai, India), triglyceride (TG) by
triglycerides-LS kit (Piramal Enterprises Ltd.), high density
lipoprotein-cholesterol (HDL) by HDL direct kit (ErbaLachema
S.R.O., Karasek, CZ.), low density lipoprotein-cholesterol (LDL) and
very lowdensity lipoprotein-cholesterol (VLDL) were done by using
diagnostic kit with semi-auto analyzer (Photometer 5010, Piramal
Healthcare V5.1, Mumbai, India).2.11. Histological analysis in CFA induced arthritis
The animals were sacriﬁced on day 28 by cervical dislocation.
Ankle joints were separated from the hind paw, immersed in 10%
buffered formalin for 24 h and processed for microtome sectioning.
Thin sections of 5 mm thickness were taken on a rotary microtome
RM 2125 RTS (Leica Microsystem Incorporation, US). The sections
were stained with haematoxylin and eosin and evaluated under
light microscope for the presence of hyperplasia of synovium,
pannus formation and destruction of joint space.12
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The data was analysed by two-way ANOVA followed by Bon-
ferroni test for multiple comparisons using Graph Pad Prism 5.03
software. Values with P < 0.05, P < 0.01 and P < 0.001 were
considered signiﬁcant.
3. Results
3.1. Acute toxicity test
Preliminary studies showed that there was no perceptible
change in the autonomic and behavioural patterns of animals on
the administration of VGE in the prescribed dose. There was no
mortality in any rat even after 14 days. No signs of toxicity were
observed in any rat.
3.2. Effect of VGE on paw volume and paw thickness in
formaldehyde induced arthritis
Subplantar administration of formaldehyde into left hind paw
showed an increase in joint diameter in all animals during the
study. When compared to control, indomethacin and VGE treated
groups showed a decrease in joint swelling in a dose dependent
manner (Fig. 1).
Maximum inhibition of joint swelling was observed in group V
(VGE 270 mg/kg) and in group VI (VGE 540 mg/kg).
3.3. Effect of VGE on paw volume and body weight in CFA induced
arthritis
There was a signiﬁcant increase in paw volume in all adjuvant
treated groups compared to normal control group. The maximum
increase in paw volumewas observed on day 14. On treatment with
VGE (135 mg/kg, 270 mg/kg and 540 mg/kg) from day 14 onwards,
signiﬁcant dose dependent inhibition was observed as compared
with arthritic control animal group (Fig. 2).
On day 28, percent inhibitions in joint swelling observed in
group V (VGE 270 mg/kg) and group VI (VGE 540 mg/kg) were 96%
and 98.5% respectively (% Inhibition was calculated by dividing
difference of paw volume on 28th day and 0 day with difference of
paw volume on 14th day and 0 day of the same group and0th 2n
d 4th 6th
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Fig. 1. Effect of Vatari Guggulu extract (VGE) on paw volume of formaldehyde treated anima
control.subsequently subtracting it from 100). No signiﬁcant changes were
observed in body weights of animals.3.4. Effect of VGE on blood parameters in CFA induced arthritis
Marked changes in the haematological parameters were
observed with induction of arthritis. Hb, RBC and packed cell vol-
ume (PCV) decreased in arthritic rats while there was an increase in
WBC, platelet count, ESR and rheumatoid factor (RF). Signiﬁcant
decrease in HDL, increase in total cholesterol (TC), triglyceride (TG),
LDL and VLDL were observed in arthritic rats. Such marked changes
in biochemical and haematological parameters were not observed
in rats treated with VGE or indomethacin (Table 1).3.5. Effect of VGE on histology of ankle joint
The joint tissue sections of CFA injected arthritic control rats
revealed major pathological changes when compared with joints of
normal rats. In CFA induced arthritic control, oedematous inﬂam-
mation, synovial hyperplasia, increased vascularity owing to vaso-
dilation, marked mononuclear inﬂammatory cell inﬁltration with
formation of lymphoid follicle at places were seen. Treatment with
VGE (540 mg/kg and VGE 270 mg/kg) showed clear reduction in
histological injury and changes as compared to arthritic control
(Fig. 3).4. Discussion
Guggulu, one of the ingredients of the formulation under study,
has been studied in inﬂammation and pain in joints, bones and
muscles.13e16 Guggulu contains active phytoconstituent known as
guggulsterones. Activation of NF-kappa B has been linked with
inﬂammatory diseases affected by guggulusterones. Gugguluster-
ones were found to suppress DNA binding of NF-kappa B induced
by TNF- a and IL-1 which has been attributed for its anti-
inﬂammatory activities.17 Triphala (contains Haritaki, Bibhitaka
and Amalaki) was found to suppress inﬂammatory processes by
reducing the production of TNF- a in adjuvant induced arthritic
mice and effective in rheumatoid arthritis.18
Vatari Guggulu was found to be safe in the preliminary toxico-
logical studies.8th 10
th
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Fig. 2. Effect of Vatari Guggulu extract (VGE) on paw volume of CFA treated animals. Values are expressed as mean ± S.E.M. of six animals. *P < 0.05, **P < 0.01 and ***P < 0.001
compared to arthritic control.
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showedmarked inhibition in joint swelling. CFA induced arthritis is
one of the most widely usedmodels as it has been shown to share a
number of clinical and immunological features with human
arthritis.11 Changes in haematological parameters were observed
due to arthritic condition.19 Pro-inﬂammatory cytokines such as
TNF a, IL-1 and IL-6, generated in the synovial tissue, are released
into the systemic circulation. These circulating cytokines tend to
alter the function of distant organs and generate a spectrum of pro-
atherogenic changes that include endothelial dysfunction, insulin
resistance, dyslipidemia, prothrombotic effects, and pro-oxidative
stress.20
The decrease in Hb, RBC reﬂects is a common extra articular
manifestation in RA.21 Anemia of chronic disease is immune driven;
cytokines and cells of the reticulo-endothelial system induce
changes in iron homoeostasis, proliferation of erythroid progenitor
cells, production of erythropoietin, and life span of red cells, all of
which contribute to the pathogenesis of anemia.22 Increase in RF,
WBC and platelet count might be due to stimulation of immune
system against invading pathogenic microorganisms.23 Increase in
ESR reﬂects the chronicity of the disease.
The increased level of cholesterol in arthritic rats might be due
to the presence of pro-inﬂammatory cytokines TNF-a and IL-I. TNF-
a increases serum TG level by stimulating LDL production.24 In ourTable 1
Effect of Vatari Guggulu extract on CFA induced arthritic rats.
Parameters Normal controla Arthritic controla Indomethac
TC (mg/dl) 96.85 ± 1.33 145.05 ± 0.88 113.85 ± 1.
TG (mg/dl) 71.69 ± 1.06 96.60 ± 1.20 78.02 ± 0.
HDL (mg/dl) 29.40 ± 0.33 16.13 ± 0.58 24.67 ± 0.
LDL (mg/dl) 53.11 ± 1.73 109.60 ± 1.16 73.57 ± 1.
VLDL(mg/dl) 14.34 ± 0.37 19.32 ± 0.87 15.60 ± 0.
Hb (gm/dl) 13.92 ± 1.27 9.97 ± 1.03 13.23 ± 1.
RBC (millions/mm3) 7.32 ± 0.87 6.58 ± 0.74 7.31 ± 0.
WBC (thousands/mm3) 8.22 ± 0.67 11.42 ± 0.79 8.89 ± 0.
Platelet (lakhs/ml) 2.46 ± 0.23 4.15 ± 0.41 2.86 ± 0.
PCV (%) 44.04 ± 1.21 30.56 ± 1.43 36.5 ± 1.
ESR (60 min) 3.76 ± 0.31 8.03 ± 0.42 3.95 ± 0.
RF (IU/ml) 7.17 ± 0.13 26.77 ± 1.46 10.78 ± 0.
a Mean ± S.E.M. (n ¼ 6) *P < 0.001.study, VGE signiﬁcantly controlled the levels of Hb, RBC, PCV, WBC,
platelet count, ESR and RF in a dose dependent manner as
compared with arthritic control and indomethacin treated groups.
Treatment with VGE re-established lipids to normal levels in
arthritic rats during the treatment (Table 1).
Histological studies showed noticeable increase in synocytes
number and decrease in number of inﬂammatory cells when
compared with standard indomethacin treated group. Treatment
with VGE 135mg/kg showedmoderate healing of joint injury when
compared with standard treated group. VGE in doses of 270 mg/kg
and 540 mg/kg demonstrated distinct reduction in histological
injury (Fig. 3).
The present study illustrates the beneﬁcial effect of VGE in
adjuvant induced arthritic rat model with respect to its anti-
arthritic activity. The puriﬁcation process of guggul, sulphur and
the addition of castor oil in the formulation may be responsible in
regulating various cytokines and disease modifying processes
thereby resulting in a comprehensive improvement in arthritis,
lipid proﬁle and haematological parameters. Guggul is also known
to have lipid lowering activity whereas triphala is a powerful anti-
oxidant that minimizes the cellular damage. This can be attributed
to the ingredients of Vatari Guggul and the speciﬁc puriﬁcation
processes prescribed in the classical texts. Based on our study,
further studies involving quantiﬁcation of certain inﬂammatoryina 10 mg/kg VGEa 135 mg/kg VGEa 270 mg/kg VGEa 540 mg/kg
53* 93.27 ± 1.53* 85.58 ± 2.00* 83.76 ± 1.18*
88* 82.52 ± 1.02* 74.13 ± 0.58* 73.21 ± 0.97*
58* 27.33 ± 0.42* 31.96 ± 0.88* 32.09 ± 0.57*
20* 49.43 ± 1.13* 38.79 ± 1.12* 37.03 ± 1.31*
48* 16.51 ± 0.37* 14.83 ± 0.67* 14.64 ± 0.52*
43* 12.76 ± 1.12* 14.67 ± 1.57* 14.97 ± 1.19*
91 7.28 ± 0.86 7.42 ± 0.83 7.45 ± 0.92
74* 9.86 ± 1.01* 8.00 ± 0.81* 7.89 ± 0.96*
33* 2.59 ± 0.32* 2.35 ± 0.16* 2.26 ± 0.26*
50* 34.33 ± 1.89* 42.62 ± 1.61* 44.16 ± 1.91*
47* 5.47 ± 0.62* 3.81 ± 0.62* 3.52 ± 0.52*
77* 9.23 ± 0.48* 8.12 ± 0.67* 9.06 ± 0.28*
Fig. 3. Effect of Vatari Guggulu extract on histology of ankle joint in experimental rats in CFA induced arthritis. 3.1) Ankle joint synovial membrane structure in normal control rat;
3.2) Chronic inﬂammation involve synovial hyperplasia with increased vascularity, oedematous inﬂammation, inﬂammatory cell inﬁltrate (involve T-lymphocytes); 3.3) Synovial
membrane structure re-establishing with the less oedema and inﬂammatory cell; 3.4) Moderate healing in the synovial membrane structure; 3.5) & 3.6) Decrease in inﬂammation
with decrease in oedematous spaces, restructuring of synovial membrane with noticeable reduction of histological injury.
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treatment of RA.
5. Conclusions
Vatari Guggulu not only reduced the inﬂammation and arthritis
in rats but also improved a number of symptoms associated with
the disease. This study clearly highlights the potential of Vatari
guggul as a reliable treatment for arthritis substantiating the claims
of the Ayurvedic system of medicine.
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